Sean Platt, MD
Retina Specialist · Beachwood, OHNPI 1518252915
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by AbbVie at 28.0% of the total. Reporting peaked in 2019 at $11,287 and has fallen 84.8% since, to $1,712 in 2025.
Across 332 payments — averaging $69.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Genentech USA, Inc.$6K
- Alimera Sciences, Inc.$4K
- Regeneron Healthcare Solutions, Inc.$2K
- Genentech, Inc.$1K
- Dutch Ophthalmic, USA$934
- plus $3K from 20 others
Across 19 payments — averaging $4103.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alimera Sciences, Inc.$57K
- ANI Pharmaceuticals, Inc.$19K
- Regeneron$1K
What the payments were for
- Consulting fees$7,73833%
- Speaking & faculty fees$2,1509%
- Travel & lodging$1,8448%
- Food & beverage$11,39049%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $6,472 |
| Genentech USA, Inc. | 49 | $5,782 |
| Alimera Sciences, Inc. | 51 | $3,975 |
| Regeneron Healthcare Solutions, Inc. | 74 | $1,719 |
| Genentech, Inc. | 6 | $1,123 |
| Dutch Ophthalmic, USA | 8 | $934 |
| Apellis Pharmaceuticals, Inc. | 32 | $792 |
| Novartis | 11 | $336 |
| Alcon | 3 | $316 |
| Astellas Pharma US Inc | 10 | $299 |
| Coherus Oncology, Inc. | 3 | $183 |
| Bausch & Lomb Americas Inc. | 5 | $174 |
| Ocular Therapeutix, Inc. | 1 | $146 |
| Eyepoint US, Inc. | 7 | $146 |
| Zimmer Biomet | 4 | $146 |
| ANI Pharmaceuticals, Inc. | 7 | $139 |
| Mallinckrodt Hospital Products Inc. | 5 | $130 |
| Neurotech Pharmaceuticals, Inc. | 4 | $89 |
| Harrow Eye, LLC | 2 | $73 |
| Kala Pharmaceuticals, Inc. | 3 | $38 |
| Sandoz | 1 | $31 |
| Carl Zeiss Meditec, Inc. | 2 | $28 |
| Vantage Technology LLC | 1 | $26 |
| Omeros Corporation | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
| Notal Vision, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OZURDEX$5,438
- Lucentis$4,257
- Iluvien$2,772
- Non-Covered Product$964
- SUSVIMO$656
- VABYSMO$520
- EVA Ophthalmic Surgical System$470
- EYLEA$291
- Syfovre$254
- EVA, combined machine$252
- TISSUEBLUE$252
- Luxor$150
- Constellation$150
- AcrySof IQ PanOptix$150
- DEXTENZA$146
- EYLEA HD$139
- NGENUITY$137
- Cimerli$135
- YUTIQ$115
- XIPERE$100
How this compares
$23,135 in reported general payments places this provider in the 75th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 262 | $7,245 |
| Ofloxacin | 250 | $2,619 |
| Latanoprost | 179 | $1,154 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 50 | $582 |
| Brimonidine Tartrate | 35 | $577 |
| Ketorolac Tromethamine | 25 | $570 |
| Dorzolamide Hcl | 21 | $366 |
| Timolol Maleate | 29 | $106 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Beachwood
- Joseph ConeyBeachwood$980K
- David MillerBeachwood$299K
- Michael NovakBeachwood$71K
- Scott PendergastBeachwood$66K
- Llewelyn RaoBeachwood$58K
- Jerome SchartmanBeachwood$30K
- Lediana GoduniBeachwood$9K
- Shawn LewisBeachwood$7K
- David ShiehBeachwood$3K
- Hernando ZegarraBeachwood$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.